Tuesday, September 23, 2008 1:00 – 2:00 pm
Room U113, M&M Building
Interventional Cardiology Division
Maple Grove, MN 55311
Boston Scientific Interventional Cardiology Division is exploring the feasibility ofbiodegradable metal stents. In particular, iron is of interest based on reportedbiocompatibility and degradation rate. Boston Scientific is performing IR&Dexperimentation to generate data upon which a recommendation can be made tothe investment board regarding the technical viability of this stent concept. One ofthe challenges discovered was that in-vitro degradation rates of the candidatemetals do not agree with observations from in-vivo experiments. One of the keydesign criteria for a degradable stent is the degradation behavior. In order to beable to assess the feasibility of these stent materials, it is necessary to understandthe time rate of mass and strength loss.
Jon Stinson is a manager at R&D Materials Analytical Lab, Boston ScientificInterventional Cardiology Division. He received a B.S. degree in Metallurgical Engineering atMTU in 1982 and MBA Management degree at the University of St. Thomas in 1992. Jon firstworked for 12 years in aerospace and defense (Williams International, Howmet, Honeywell,Alliant Techsystems) as a metallurgical engineer on R&D projects for gas turbine engines andordnance. Then he worked for 14 years in the medical device industry as a metallurgicalengineer and materials lab manager on R&D projects for intraluminal catheter, guidewire, andimplant products.